LifeStance Health Group, Inc. Files Definitive Proxy Statement (DEF 14A)

TL;DR

<b>LifeStance Health Group, Inc. has filed its Definitive Proxy Statement (DEF 14A) for the fiscal year ending December 31, 2023, detailing executive compensation and equity awards.</b>

AI Summary

LifeStance Health Group, Inc. (LFST) filed a Proxy Statement (DEF 14A) with the SEC on April 23, 2024. LifeStance Health Group, Inc. filed a Definitive Proxy Statement (DEF 14A) on April 23, 2024. The filing pertains to the fiscal year ending December 31, 2023. The company's principal executive offices are located in Scottsdale, AZ. The filing includes details on equity awards, including fair value changes and vesting conditions. Key executive compensation components are detailed, though specific dollar amounts are not yet provided in this snippet.

Why It Matters

For investors and stakeholders tracking LifeStance Health Group, Inc., this filing contains several important signals. This filing is crucial for shareholders to understand executive compensation structures and potential impacts on company performance. Shareholders will use this information to make informed voting decisions on executive pay and other corporate matters at the upcoming annual meeting.

Risk Assessment

Risk Level: — LifeStance Health Group, Inc. shows moderate risk based on this filing. The provided text is a header and index for a DEF 14A filing, lacking specific financial performance data or forward-looking statements that would indicate a higher risk level.

Analyst Insight

Review the full DEF 14A filing to analyze executive compensation details, equity award valuations, and any shareholder proposals to inform investment decisions.

Key Numbers

• 2024-04-23 — Filing Date (Date the DEF 14A was filed)
• 2023-12-31 — Fiscal Year End (The period the filing covers)
• 2024-06-03 — Report Date (Conformed period of report)

Key Players & Entities

• LifeStance Health Group, Inc. (company) — Filer of the DEF 14A
• Kenneth Burdick (person) — Mentioned in relation to equity awards and compensation
• Michael K. Lester (person) — Mentioned in relation to equity awards and compensation
• Scottsdale, AZ (location) — Business and mailing address of the company

FAQ

Industry Context

LifeStance Health Group operates within the health services sector, focusing on providing mental and behavioral healthcare services.

Regulatory Implications

The filing is a standard DEF 14A (Definitive Proxy Statement) required by the SEC for public companies, detailing information relevant to shareholder voting.

What Investors Should Do

1. Analyze the full DEF 14A for detailed executive compensation packages and equity award valuations.
2. Examine any shareholder proposals or director nominations presented in the filing.
3. Compare the disclosed executive compensation with industry benchmarks and the company's financial performance.

Year-Over-Year Comparison

This is the initial DEF 14A filing provided in the snippet, so a comparison to a previous filing is not possible based on the given data.

Key Financial Figures

• $0.01 — f the Company's common stock, par value $0.01 per share, for use at the Company's ann

Filing Documents

• lfst-20240422.htm (DEF 14A) — 1642KB
• img25511030_0.jpg (GRAPHIC) — 61KB
• img25511030_1.jpg (GRAPHIC) — 6KB
• img25511030_2.jpg (GRAPHIC) — 61KB
• img25511030_3.jpg (GRAPHIC) — 22KB
• img25511030_4.jpg (GRAPHIC) — 45KB
• img25511030_5.jpg (GRAPHIC) — 50KB
• img25511030_6.jpg (GRAPHIC) — 48KB
• img25511030_7.jpg (GRAPHIC) — 30KB
• img25511030_8.jpg (GRAPHIC) — 1393KB
• img25511030_9.jpg (GRAPHIC) — 85KB
• 0000950170-24-046929.txt (&nbsp;) — 6769KB
• lfst-20240422.xsd (EX-101.SCH) — 40KB
• lfst-20240422_htm.xml (XML) — 368KB

Security Ownership of Certain Beneficial Owners and Management and Related Party Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Party Stockholder Matters 42 Beneficial Ownership 42 Equity Compensation Plan Information 44 Certain Relationships and Related Transactions 45 Related Person Transactions Policy 45 Audit Committee Report 46 Additional Information 47 Requirements for Stockholder Proposals to be Considered for Inclusion in our Proxy Materials 47 Requirements for Stockholder Proposals to be Brought Before an Annual Meeting 47 Incorporation by Reference 47 Householding 47 Voting by Telephone or the Internet 47 Other Matters 48 LifeStance Health Group, Inc. PROXY STATEMENT FOR ANNUAL MEETING OF STOCKHOLDERS June 3, 2024 INTRODUCTION This Proxy Statement provides information for stockholders of LifeStance Health Group, Inc. ("we," "us," "our," "LifeStance" and the "Company"), as part of the solicitation of proxies by the Company and its board of directors (the "Board of Directors") from holders of the outstanding shares of the Company's common stock, par value $0.01 per share, for use at the Company's annual meeting of stockholders to be held in a virtual format at www.proxydocs.com/LFST at 1:00 p.m. Eastern Time on June 3, 2024, and at any adjournments or postponements thereof (the "Annual Meeting"). At the Annual Meeting, stockholders will be asked to vote either directly or by proxy on the following matters discussed herein: 1. Election of the three director nominees named in the Proxy Statement to serve until the 2027 annual meeting of stockholders; 2. Ratification of the appointment of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for the year ended December 31, 2024; 3. Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers; 4. Approval, on a non-binding advisory basis, of the frequency of future "say on pay" votes; and 5. Transacting such other

View Full Filing

View this DEF 14A filing on SEC EDGAR